lobenzarit has been researched along with Myocarditis in 3 studies
lobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpd
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim was to test the efficacy of the immune system modulator lobenzarit disodium in the treatment of coxsackievirus B3 myocarditis." | 7.68 | Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993) |
| "The aim of this study is to test the therapeutic efficacy of immunomodulation with lobenzarit disodium (CCA) upon coxsackievirus B3 (CB3) myocarditis." | 7.68 | The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993) |
| "Lobenzarit (CCA) is a newly developed immunomodulating drug that has been demonstrated to enhance suppressor T-cell number and function." | 5.28 | Effects of lobenzarit on murine acute viral myocarditis. ( Kanda, T; Murata, K; Suzuki, T; Yokoyama, T, 1992) |
| "The aim was to test the efficacy of the immune system modulator lobenzarit disodium in the treatment of coxsackievirus B3 myocarditis." | 3.68 | Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993) |
| "The aim of this study is to test the therapeutic efficacy of immunomodulation with lobenzarit disodium (CCA) upon coxsackievirus B3 (CB3) myocarditis." | 3.68 | The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis. ( Hiraoka, Y; Kishimoto, C; Kurokawa, M; Kuroki, Y; Matsushita, I; Ochiai, H; Sasayama, S; Takada, H, 1993) |
| "Lobenzarit (CCA) is a newly developed immunomodulating drug that has been demonstrated to enhance suppressor T-cell number and function." | 1.28 | Effects of lobenzarit on murine acute viral myocarditis. ( Kanda, T; Murata, K; Suzuki, T; Yokoyama, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kishimoto, C | 2 |
| Takada, H | 2 |
| Kuroki, Y | 2 |
| Matsushita, I | 2 |
| Hiraoka, Y | 2 |
| Kurokawa, M | 2 |
| Ochiai, H | 2 |
| Sasayama, S | 2 |
| Yokoyama, T | 1 |
| Kanda, T | 1 |
| Suzuki, T | 1 |
| Murata, K | 1 |
3 other studies available for lobenzarit and Myocarditis
| Article | Year |
|---|---|
Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Immunosuppressive Agents; Male; Mice; Mice | 1993 |
The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Coxsackievirus Infections; Enterovirus B, Human; | 1993 |
Effects of lobenzarit on murine acute viral myocarditis.
Topics: Adjuvants, Immunologic; Animals; Blood Cell Count; Encephalomyocarditis virus; Enterovirus Infection | 1992 |